Two Host Factors Regulate Persistence of H7a-Specific T Cells Injected in Tumor-Bearing Mice

Background Injection of CD8 T cells primed against immunodominant minor histocompatibility antigens (MiHA) such as H7a can eradicate leukemia and solid tumors. To understand why MiHA-targeted T cells have such a potent antitumor effect it is essential to evaluate their in vivo behavior. In the prese...

Ausführliche Beschreibung